The Effects of Vinblastine on Endothelial Cells

REFERENCES

• Acharya G., Park K. Mechanisms of controlled drug release from drug-eluting stents. Advanced Drug Delivery Reviews 2006; 58: 387–401
   PubMed Web of Science ®Google Scholar
• Axel D. I., Kunert W., Goggelmann C., Oberhoff M., Herdeg C., Kuttner A., Wild D. H., Brehm B. R., Riessen R., Koveker G., Karsch K. R. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997; 96: 636–645
   PubMed Web of Science ®Google Scholar
• Colombo A., Drzewiecki J., Banning A., Grube E., Hauptmann K., Silber S., Dudek D., Fort S., Schiele F., Zmudka K., Guagliumi G., Russell M. E. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation 2003; 108: 788–794
   PubMed Web of Science ®Google Scholar
• Fields R. D., Lancaster M. V. Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. American Biotechnology Laboratory 1993; 11: 48–50
   PubMed Web of Science ®Google Scholar
• Finn A. V., Kolodgie F. D., Harnek J., Guerrero L. J., Acampado E., Tefera K., Skorija K., Weber D. K., Gold H. K., Virmani R. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation 2005; 112: 270–278
   PubMed Web of Science ®Google Scholar
• Fujii T., Kondo Y., Kumasaka M., Ohki K. Stimulation of tubulin-dependent atpase activity in microtubule proteins from porcine brain by vinblastine. Journal of Neurochemistry 1982; 39: 1587–1593
   PubMed Web of Science ®Google Scholar
• Hayot C., Farinelle S., De Decker R., Decaestecker C., Darro F., Kiss R., Van Damme M. In vitro pharmacological characterizations of the anti-angiogenic and anti-tumor cell migration properties mediated by microtubule-affecting drugs, with special emphasis on the organization of the actin cytoskeleton. International Journal of Oncology 2002; 21: 417–425
   PubMed Web of Science ®Google Scholar
• Joner M., Finn A. V., Farb A., Mont E. K., Kolodgie F. D., Ladich E., Kutys R., Skorija K., Gold H. K., Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. Journal of the American College of Cardiology 2006; 48: 193–202
   PubMed Web of Science ®Google Scholar
• Kamath K. R., Barry J. J., Miller K. M. The Taxustrade mark drug-eluting stent: A new paradigm in controlled drug delivery. Advanced Drug Delivery Reviews 2006; 58: 412–436
   PubMed Web of Science ®Google Scholar
• Larson E. M., Doughman D. J., Gregerson D. S., Obritsch W. F. A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Investigative Ophthalmology and Visual Science 1997; 38: 1929–1933
   PubMed Web of Science ®Google Scholar
• Lee C. H., Lim J., Low A., Tan H. C., Lim Y. T. Late angiographic stent thrombosis of polymer based paclitaxel eluting stent. Heart 2006; 92: 551–553
   PubMed Web of Science ®Google Scholar
• Liggins R. T., Hunter W. L., Burt H. M. Solid-state characterization of paclitaxel. Journal of Pharmaceutical Sciences 1997; 86: 1458–1463
   PubMed Web of Science ®Google Scholar
• McLucas E., Gallagher H., Rochev Y., Carroll W. M., Gorelov A., Smith J. J. Global gene expression analysis of the effects of vinblastine on endothelial cells, when eluted from a thermo-responsive polymer. Journal of Biomedical Materials Research Part A 2006; 79A: 246–253
   Web of Science ®Google Scholar
• Mitra A. K., Agrawal D. K. In stent restenosis: Bane of the stent era. Journal of Clinical Pathology 2006; 59: 232–239
   PubMed Web of Science ®Google Scholar
• Moses J. W., Leon M. B., Popma J. J., Fitzgerald P. J., Holmes D. R., O'Shaughnessy C., Caputo R. P., Kereiakes D. J., Williams D. O., Teirstein P. S., Jaeger J. L., Kuntz R. E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine 2003; 349: 1315–1323
   PubMed Web of Science ®Google Scholar
• Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T.-T., Yu V. L., Miller D. K. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. 1995; 376: 37–43
   Google Scholar
• O'Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. European Journal of Biochemisty 2000; 267: 5421–5426
   PubMedGoogle Scholar
• Okouneva T., Hill B. T., Wilson L., Jordan M. A. The effects of vinflunine, vinorelbine, and vinblastine on centromere dynamics. Molecular Cancer Therapeutics 2003; 2: 427–436
   PubMed Web of Science ®Google Scholar
• Pasquier E., Honore S., Pourroy B., Jordan M. A., Lehmann M., Briand C., Braguer D. Antiangiogenic concentrations of paclitaxel induce an increase in microtubule dynamics in endothelial cells but not in cancer cells. Cancer Research 2005; 65: 2433–2440
   PubMed Web of Science ®Google Scholar
• Serruys P. W., de Jaegere P., Kiemeneij F., Macaya C., Rutsch W., Heyndrickx G., Emanuelsson H., Marco J., Legrand V., Materne P., Belardi J., Sigwart U., Colombo A., Goy J. J., van den Heuvel P., Delcan J., Morel M.-A., The Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. New England Journal of Medicine 1994; 331: 489–495
   PubMed Web of Science ®Google Scholar
• Stone G. W., Ellis S. G., Cox D. A., Hermiller J., O'Shaughnessy C., Mann J. T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J. J., Russell M. E. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004a; 109: 1942–1947
   PubMed Web of Science ®Google Scholar
• Stone G. W., Ellis S. G., Cox D. A., Hermiller J., O'Shaughnessy C., Mann J. T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J. J., Russell M. E., the TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. New England Journal of Medicine 2004b; 350: 221–231
   PubMed Web of Science ®Google Scholar
• Tung R., Kaul S., Diamond G. A., Shah P. K. Narrative review: Drug-eluting stents for the management of restenosis: A critical appraisal of the evidence. Annals of Internal Medicine 2006; 144: 913–919
   PubMed Web of Science ®Google Scholar
• Wilson L., Jordan M. A., Morse A., Margolis R. L. Interaction of vinblastine with steady-state microtubules in vitro. Journal of Molecular Biology 1982; 159: 125–149
   Google Scholar